C. Morris

发表

Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice.

N. LeBrasseur, K. Walsh, Y. Izumiya, 2008, Cell metabolism.

Bowman-Birk inhibitor attenuates dystrophic pathology in mdx mice.

H. Sweeney, J. Selsby, C. Morris, 2010, Journal of applied physiology.

Attenuation of skeletal muscle atrophy via protease inhibition.

H. Sweeney, A. R. Kennedy, C. Morris, 2005, Journal of applied physiology.

The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle.

B. Spiegelman, N. LeBrasseur, Wenli Yang, 2007, Cell metabolism.

Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibody

James R. Apgar, K. Parris, K. Svenson, 2016, mAbs.

Reduced serum myostatin concentrations associated with genetic muscle disease progression

Hanns Lochmüller, T. Evangelista, V. Straub, 2017, Journal of Neurology.

Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures

Hongtu Zhu, M. Styner, Jiahui Wang, 2016, Skeletal Muscle.

A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys

Mark Johnson, P. Bansal, A. Robertson, 2017, Skeletal Muscle.

Myostatin inhibition using mRK35 produces skeletal muscle growth and tubular aggregate formation in wild type and TgACTA1D286G nemaline myopathy mice

Zizhao Zhang, N. Laing, M. Lawlor, 2018, Human molecular genetics.

Voluntary wheel running complements microdystrophin gene therapy to improve muscle function in mdx mice

R. Grange, D. Mack, R. McMillan, 2021, Molecular therapy. Methods & clinical development.

Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures

Hongtu Zhu, M. Styner, Jiahui Wang, 2016, Skeletal Muscle.

Dystrophic muscle improvement in zebrafish via increased heme oxygenase signaling.

M. Gasperini, L. Kunkel, J. Widrick, 2014, Human molecular genetics.

Mechanisms and strategies to counter muscle atrophy.

E. Barton, C. Morris, 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

Distinct protein degradation profiles are induced by different disuse models of skeletal muscle atrophy.

H. Seeherman, S. Jelinsky, P. Yaworsky, 2011, Physiological genomics.

Distinct Protein Degradation Profiles Are Induced by Different Disuse Models of 1 Skeletal Muscle Atrophy 2 Running Title: Distinct Protein Degradation Pathways in Muscle Atrophy

H. Seeherman, S. Jelinsky, P. Yaworsky, 2011 .

A proteasome inhibitor fails to attenuate dystrophic pathology in mdx mice

J. Selsby, C. Morris, L. Morris, 2012, PLoS currents.

Quantitative measurements of GDF‐8 using immunoaffinity LC‐MS/MS

L. Fitz, H. Neubert, H. Rong, 2016, Proteomics. Clinical applications.

The role of GH and IGF-I in mediating anabolic effects of testosterone on androgen-responsive muscle.

H. Vandenburgh, J. Shansky, T. Travison, 2010, Endocrinology.

Treatment with rhBMP12 or rhBMP13 increase the rate and the quality of rat Achilles tendon repair

H. Seeherman, S. Jelinsky, D. Ellis, 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures

Hongtu Zhu, M. Styner, Jiahui Wang, 2016, Skeletal Muscle.

Muscle-Derived Proteins as Serum Biomarkers for Monitoring Disease Progression in Three Forms of Muscular Dystrophy

K. Bushby, Hanns Lochmüller, V. Straub, 2015, Journal of neuromuscular diseases.

A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type I

Eric T. Wang, Nicole E. Bodycombe, E. Wang, 2017, Human molecular genetics.

Membrane recruitment of nNOSµ in microdystrophin gene transfer to enhance durability

V. Ricotti, C. Morris, J. P. Gonzalez, 2019, Neuromuscular Disorders.

Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A

Jamie L. Marshall, J. Spinazzola, J. Harms, 2016, Translational Psychiatry.

Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss.

P. Sebastiani, N. LeBrasseur, S. Bhasin, 2007, The Journal of clinical endocrinology and metabolism.

Mark Johnson, P. Bansal, A. Robertson, 2017, Skeletal Muscle.

A proteasome inhibitor fails to attenuate dystrophic pathology in mdx mice.

J. Selsby, C. Morris, L. Sweeney, 2012, PLOS Currents.

Treatment with rhBMP12 or rhBMP13 increase the rate and the quality of rat Achilles tendon repair

H. Seeherman, S. Jelinsky, D. Ellis, 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.